These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35028611)

  • 1. Targeted blockade of immune mechanisms inhibit B precursor acute lymphoblastic leukemia cell invasion of the central nervous system.
    Rajakumar SA; Grandal I; Minden MD; Hitzler JK; Guidos CJ; Danska JS
    Cell Rep Med; 2021 Dec; 2(12):100470. PubMed ID: 35028611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the thioredoxin system as a novel strategy against B-cell acute lymphoblastic leukemia.
    Fidyt K; Pastorczak A; Goral A; Szczygiel K; Fendler W; Muchowicz A; Bartlomiejczyk MA; Madzio J; Cyran J; Graczyk-Jarzynka A; Jansen E; Patkowska E; Lech-Maranda E; Pal D; Blair H; Burdzinska A; Pedzisz P; Glodkowska-Mrowka E; Demkow U; Gawle-Krawczyk K; Matysiak M; Winiarska M; Juszczynski P; Mlynarski W; Heidenreich O; Golab J; Firczuk M
    Mol Oncol; 2019 May; 13(5):1180-1195. PubMed ID: 30861284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of CXCR4-mediated bone marrow colonization in CNS infiltration by T cell acute lymphoblastic leukemia.
    Jost TR; Borga C; Radaelli E; Romagnani A; Perruzza L; Omodho L; Cazzaniga G; Biondi A; Indraccolo S; Thelen M; Te Kronnie G; Grassi F
    J Leukoc Biol; 2016 Jun; 99(6):1077-87. PubMed ID: 26931577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL7R is associated with CNS infiltration and relapse in pediatric B-cell precursor acute lymphoblastic leukemia.
    Alsadeq A; Lenk L; Vadakumchery A; Cousins A; Vokuhl C; Khadour A; Vogiatzi F; Seyfried F; Meyer LH; Cario G; Hobeika E; Debatin KM; Halsey C; Schrappe M; Schewe DM; Jumaa H
    Blood; 2018 Oct; 132(15):1614-1617. PubMed ID: 30154115
    [No Abstract]   [Full Text] [Related]  

  • 5. NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia.
    Lopez-Millan B; Sanchéz-Martínez D; Roca-Ho H; Gutiérrez-Agüera F; Molina O; Diaz de la Guardia R; Torres-Ruiz R; Fuster JL; Ballerini P; Suessbier U; Nombela-Arrieta C; Bueno C; Menéndez P
    Leukemia; 2019 Jul; 33(7):1557-1569. PubMed ID: 30635633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.
    Shin M; Matsuo K; Tada T; Fukushima H; Furuta H; Ozeki S; Kadowaki T; Yamamoto K; Okamoto M; Jimi E
    Carcinogenesis; 2011 Nov; 32(11):1634-40. PubMed ID: 21890459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of neuroblastoma bone invasion/metastasis in established bone metastatic model of SY5Y and KCNR cell lines.
    Zhao H; Cai W; Li S; Da Z; Sun H; Ma L; Lin Y; Zhi D
    Childs Nerv Syst; 2013 Jul; 29(7):1097-105. PubMed ID: 23559392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell acute lymphoblastic leukemia cells mediate RANK-RANKL-dependent bone destruction.
    Rajakumar SA; Papp E; Lee KK; Grandal I; Merico D; Liu CC; Allo B; Zhang L; Grynpas MD; Minden MD; Hitzler JK; Guidos CJ; Danska JS
    Sci Transl Med; 2020 Sep; 12(561):. PubMed ID: 32938796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MLL-rearranged acute lymphoblastic leukaemia stem cell interactions with bone marrow stroma promote survival and therapeutic resistance that can be overcome with CXCR4 antagonism.
    Sison EA; Rau RE; McIntyre E; Li L; Small D; Brown P
    Br J Haematol; 2013 Mar; 160(6):785-97. PubMed ID: 23294096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric acute lymphoblastic leukemia-Conquering the CNS across the choroid plexus.
    März M; Meyer S; Erb U; Georgikou C; Horstmann MA; Hetjens S; Weiß C; Fallier-Becker P; Vandenhaute E; Ishikawa H; Schroten H; Dürken M; Karremann M
    Leuk Res; 2018 Aug; 71():47-54. PubMed ID: 30005184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous reversion of a lineage switch following an initial blinatumomab-induced ALL-to-AML switch in
    Wölfl M; Rasche M; Eyrich M; Schmid R; Reinhardt D; Schlegel PG
    Blood Adv; 2018 Jun; 2(12):1382-1385. PubMed ID: 29898879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD9, a key actor in the dissemination of lymphoblastic leukemia, modulating CXCR4-mediated migration via RAC1 signaling.
    Arnaud MP; Vallée A; Robert G; Bonneau J; Leroy C; Varin-Blank N; Rio AG; Troadec MB; Galibert MD; Gandemer V
    Blood; 2015 Oct; 126(15):1802-12. PubMed ID: 26320102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuated measles virus controls pediatric acute B-lineage lymphoblastic leukemia in NOD/SCID mice.
    Lühl NC; Zirngibl F; Dorneburg C; Wei J; Dahlhaus M; Barth TF; Meyer LH; Queudeville M; Eckhoff S; Debatin KM; Beltinger C
    Haematologica; 2014 Jun; 99(6):1050-61. PubMed ID: 24700491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the RANK/RANKL signaling with osteoprotegerin prevents castration-induced acceleration of bone metastasis in castration-insensitive prostate cancer.
    Takayama K; Inoue T; Narita S; Maita S; Huang M; Numakura K; Tsuruta H; Saito M; Maeno A; Satoh S; Tsuchiya N; Habuchi T
    Cancer Lett; 2017 Jul; 397():103-110. PubMed ID: 28373003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAC2, AEP, and ICAM1 expression are associated with CNS disease in a mouse model of pre-B childhood acute lymphoblastic leukemia.
    Holland M; Castro FV; Alexander S; Smith D; Liu J; Walker M; Bitton D; Mulryan K; Ashton G; Blaylock M; Bagley S; Connolly Y; Bridgeman J; Miller C; Krishnan S; Dempsey C; Masurekar A; Stern P; Whetton A; Saha V
    Blood; 2011 Jul; 118(3):638-49. PubMed ID: 21606482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-risk acute lymphoblastic leukemia cells with bcr-abl and INK4A/ARF mutations retain susceptibility to alloreactive T cells.
    Young FM; Campbell A; Emo KL; Jansson J; Wang PY; Jordan CT; Mullen CA
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):622-30. PubMed ID: 18489987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemosensitivity is differentially regulated by the SDF-1/CXCR4 and SDF-1/CXCR7 axes in acute lymphoblastic leukemia with MLL gene rearrangements.
    Ando N; Furuichi Y; Kasai S; Tamai M; Harama D; Kagami K; Abe M; Goi K; Inukai T; Sugita K
    Leuk Res; 2018 Dec; 75():36-44. PubMed ID: 30453100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Central nervous system involvement in acute lymphoblastic leukemia].
    Yao H
    Rinsho Ketsueki; 2019; 60(9):1212-1220. PubMed ID: 31597846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric predictive scoring systems for common fusions ETV6/RUNX1, BCR/ABL1, TCF3/PBX1 and rearrangements of the KMT2A gene, proposed for the initial cytogenetic approach in cases of B-acute lymphoblastic leukemia.
    Tsagarakis NJ; Papadhimitriou SI; Pavlidis D; Marinakis T; Kostopoulos IV; Stiakaki E; Polychronopoulou S; Paterakis G
    Int J Lab Hematol; 2019 Jun; 41(3):364-372. PubMed ID: 30730614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notch/CXCR4 Partnership in Acute Lymphoblastic Leukemia Progression.
    Tsaouli G; Ferretti E; Bellavia D; Vacca A; Felli MP
    J Immunol Res; 2019; 2019():5601396. PubMed ID: 31346528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.